Next Article in Journal
Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer
Next Article in Special Issue
The Mistletoe and Breast Cancer (MAB) Study: A UK Mixed-Phase, Pilot, Placebo-Controlled, Double-Blind, Randomised Controlled Trial
Previous Article in Journal
The Imaging of Primary Fallopian Tube Carcinoma: A Literature Review
Previous Article in Special Issue
Evaluating the Impact of Weekly Physical Performance Reports on Daily Physical Activity and Symptoms Among Cancer Survivors: Secondary Analysis of a Randomized Controlled Trial
 
 
Article

Article Versions Notes

Cancers 2025, 17(18), 2987; https://doi.org/10.3390/cancers17182987
Action Date Notes Link
article html file updated 12 September 2025 12:13 CEST Original file https://www.mdpi.com/2072-6694/17/18/2987/html
article supplementary file uploaded. 12 September 2025 12:12 CEST - https://www.mdpi.com/2072-6694/17/18/2987#supplementary
article pdf uploaded. 12 September 2025 12:12 CEST Version of Record https://www.mdpi.com/2072-6694/17/18/2987/pdf
article xml uploaded. 12 September 2025 12:12 CEST Update https://www.mdpi.com/2072-6694/17/18/2987/xml
article xml file uploaded 12 September 2025 12:12 CEST Original file -
Back to TopTop